NEWS

UC San Diego News Center

MENU

News Archive - Yadira Galindo

  • Powered by Chemo: Patient with Advanced Pancreatic Cancer Tackles Ironman Triathlon

    Despite a diagnosis of stage IV pancreatic cancer and ongoing chemotherapy, Mike Levine boarded a plane this past weekend destined for Kona, Hawaii, where he will compete in one of the most grueling of physical competitions: the Ironman World Championship. Cheering him on will be his wife Jan, friends…

  • DNA Mutations Shed in Blood Predicts Response to Immunotherapy in Patients with Cancer

    In a first-of-its-kind study, University of California San Diego School of Medicine researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies.

  • Exosomes are the Missing Link to Insulin Resistance in Diabetes

    Chronic tissue inflammation resulting from obesity is an underlying cause of insulin resistance and type 2 diabetes. But the mechanism by which this occurs has remained cloaked, until now. In a paper, University of California San Diego School of Medicine researchers identified exosomes — extremely…

  • Drug Combination May Improve Impact of Immunotherapy in Head and Neck Cancer

  • Brain Powered: Increased Physical Activity Among Breast Cancer Survivors Boosts Cognition

    It is estimated that up to 75 percent of breast cancer survivors experience problems with cognitive difficulties following treatments, perhaps lasting years. Currently, few science-based options are available to help. University of California San Diego School of Medicine researchers report in a pilot…

  • Researchers Develop New Strategy to Target KRAS Mutant Cancer

    In a new study, published this month in Cancer Discovery, University of California San Diego School of Medicine researchers report that approximately half of lung and pancreatic cancers that originate with a KRAS mutation become addicted to the gene as they progress.

  • Blood Biopsy Reveals Unique, Targetable Genetic Alterations in Patients with Rare Cancer

    Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people…

  • Americans are Quitting Smoking in Higher Numbers; Study Suggests E-cigarettes Help

    University of California San Diego School of Medicine and Moores Cancer Center researchers performed a population-level analysis of national surveys conducted from 2001 to 2015 and found that in the United States the smoking cessation rate increased for the first time in 15 years. The study suggests…

  • Repurposed Asthma Drug Shows Blood Sugar Improvement among Some Diabetics

    After 12 weeks of taking an anti-asthma drug, a subset of patients with type 2 diabetes showed a clinically significant reduction in blood glucose during a randomized, double blind, placebo-controlled clinical trial, report University of California San Diego School of Medicine and University of Michigan…